local steering group

The local steering group of BraineHealth works for the interest of and leverage on the municipal of Norrtälje and Campus Roslagen.

Kurt Pettersson


Kurt Pettersson is professor in limnology and former prefekt/president of the Erken Laboratory in Norrtälje.

Professor Pettersson is the chairman of Roslagens Sparbank (a part of Swedbank)

Pettersson is also a member of the board of Campus Roslagen AB owned by the municipal of Norrtälje.

Ulf Linderholm

ceo campus roslagen

Ulf is responsible for to improve the infrastructure and environment of Campus Roslagen. 

Ulf will in different ways support BraineHealth´s growth and integration in the concept of Campus Roslagen.

Isabella Svensson Rissanen

co-founder and program manager

Isabella is co-founder of BraineHealth, where she manages AI solutions and content development.

She is also co-founder and board member of Lugn&Ro Sverige AB, where she co-developed the Lugn&Ro Doktorn, a telemedicine solution with virtual doctor appointments.

Isabella is an experienced project and IT-system manager, and Quality Management System developer for healthcare solutions within diabetes, asthma, and hypertoni.

She is responsible for implementation of multiple public digital healthcare services, 1177 Vårdguiden, in Stockholm County.

She holds studies in science theory, culture, and media from Stockholm University.

Roger Svensson

founder and ceo

Roger is the founder and President of BraineHealth, the creator of Diagnosio and Diabetio, an artificial intelligence application suite for healthcare.

Roger is serial entrepreneur and former research leader at Karolinska Institutet, where he successfully spun off several healthcare companies from seed to IPO. The latest one to IPO is CRAD AB, a company providing advanced radiation therapy for cancer treatment worldwide with current market capital of MSEK 1 087.

Roger is also the founder and CEO of Lugn&Ro Sverige AB, a healthcare provider company with 70 employees, where Diagnosio is being improved by its doctors and patients.

Roger has PhD from Stockholm University / Karolinska Institutet, and MBA from Stockholm School of Economics.